Weight loss and, even more importantly, weight loss maintenance are required to reduce the health risks associated with obesity. Conservative treatment by lifestyle changes and pharmacotherapy is often unsuccessful in the long-term, and bariatric surgery is only indicated in the very obese. Could intragastric balloon treatment bridge the gap between pharmacotherapy and surgery in patients who fail to respond to drugs?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome
Diabetology & Metabolic Syndrome Open Access 19 December 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 3–5 June 1997. Report No.: WHO/NUT/NCD/98.1 (1997).
[No authors listed] Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes. Res. 6 (Suppl. 2), 51S–209S (1998).
National Institute of Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. National Institute of Clinical Excellence [online], (2006).
Schapiro, M. et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19–21, 1987. Gastrointest. Endosc. 33, 323–327 (1987).
Mathus-Vliegen, E. M. & Tytgat, G. N. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by 1-year balloon-free follow-up. Gastrointest. Endosc. 61, 19–27 (2005).
Crea, N. et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes. Surg. 19, 1084–1088 (2009).
Pasquali, R. et al. Mechanisms of action of the intragastric balloon in obesity: effects on hunger and satiety. Appetite 15, 3–11 (1990).
Geliebter, A., Westreich, S., Gage, D. & Hashim, S. A. Intragastric balloon reduces food intake and body weight in rats. Am. J. Physiol. 251, R794–R797 (1986).
Negrin Dastis, S. et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 41, 575–580 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Mathus-Vliegen, E. Intragastric balloons—a bubble to combat the obesity bubble?. Nat Rev Gastroenterol Hepatol 7, 7–8 (2010). https://doi.org/10.1038/nrgastro.2009.214
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.214
This article is cited by
-
Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome
Diabetology & Metabolic Syndrome (2016)
-
Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment
Endocrine (2014)
-
Morbidly Obese are Ghrelin and Leptin Hyporesponders with Lesser Intragastric Balloon Treatment Efficiency
Obesity Surgery (2011)
